home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

197 rows where filing_period = "second_quarter", filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 197 ✖

filing_year 1

  • 2011 · 197 ✖

filing_period 1

  • second_quarter · 197 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1107122 RED+BLUE STRATEGIES 083b5278-7828-4d75-b631-081680ebf050 Q2 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2011 second_quarter PHA HR 1946, Community Pharmacy Fairness Act Rules, regualtions and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-07-01T15:05:13.563000-04:00
1107482 MEREDITH MCGEHEE 8ac91a17-fed4-48e4-9a9b-580e8e0b1819 Q2 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2011 second_quarter PHA Funding for programs to develop AIDS vaccines tarted toward the developing world; Working with the Global Health Technologies Coalition to educate about research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR and appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's model; Providing input of foreign assistance reform from a global health perspective; Funding and budget issues as related to USAID. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-05T14:28:52.070000-04:00
1107576 CYBER SECURITY RESEARCH CONSULTANTS, LLC dc9fc652-ee94-4ad9-958f-d45c1ce4e110 Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2011 second_quarter PHA Food and Drug Safety Globalizatin Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2011-07-05T21:08:55.563000-04:00
1107701 PARRY, ROMANI, DECONCINI & SYMMS e4c7f653-3e3d-4ced-ae51-7b91d14275cb Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2011 second_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2011-07-06T12:49:09.633000-04:00
1108066 PUBLIC AFFAIRS RESOURCES, INC. 9a90fce1-7093-47a9-a6d0-ed902f74b3c4 Q2 PUBLIC AFFAIRS RESOURCES, INC. 31270 PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) 2011 second_quarter PHA Electronic Professional Inserts in lies of Paper, FDA HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-07T12:58:21.857000-04:00
1108335 RED+BLUE STRATEGIES 6da3b9f9-87ca-4cf0-8d75-a186b8dd77ab Q2 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2011 second_quarter PHA H.R. 1946 - The Community Pharmacy Fairness Act, which allows for an anti-trust exception for certain pharmacies. Issues regarding the approval and coverage of a recently approved drug, Makena. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-07-08T09:20:06.560000-04:00
1108565 BUCHANAN INGERSOLL & ROONEY PC 2a42bac7-5cbb-410d-b7cc-8290d7153cf3 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 SHIRE PHARMACEUTICALS INC 2011 second_quarter PHA Life Sciences Investment Act; ESRD bundling, ESRD Quality Incentive program; orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-08T13:19:56.510000-04:00
1108695 INJURED WORKERS PHARMACY 3a6fceb3-eda7-495c-9931-df31d99df3ef Q2 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2011 second_quarter PHA Transparency of Pharmacy Benefit Managers (Bill sponsored by Rep. Cathy McMorris Rodgers (R-WA) and Sen. Mark Pryor (D-AR) Longshore and Harbor Workers Amendment Act of 2011 sponsored by Sen. Johnny Isakson (R-GA) HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-08T14:40:05.627000-04:00
1108723 PARRY, ROMANI, DECONCINI & SYMMS 423624a8-f9f1-4bfe-90f4-2b03140f9aae Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T14:58:18.923000-04:00
1108726 PARRY, ROMANI, DECONCINI & SYMMS ac918148-70ff-4dce-b41f-a654227b3c41 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-07-08T15:08:20.700000-04:00
1108745 PARRY, ROMANI, DECONCINI & SYMMS 325761ad-b210-4806-867e-96a937079b48 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T15:35:33.777000-04:00
1108770 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 726911d7-fcb4-49ea-9ce3-f8f8b588f2c7 Q2 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2011 second_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   105753 0 0 2011-07-08T15:57:47.607000-04:00
1108786 PARRY, ROMANI, DECONCINI & SYMMS ac5a2f7d-cfb0-4e38-a0f2-2eb58c0b80ac Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T16:03:55.353000-04:00
1108798 PARRY, ROMANI, DECONCINI & SYMMS 1b4a13f8-f463-4395-b024-66054c7fc74a Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-07-08T16:16:02.027000-04:00
1108812 INDEPENDENT PHARMACY COOPERATIVE 850445e4-4c28-44eb-996f-65a628ec2ccf Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2011 second_quarter PHA Short-Cycle dispensing of medication in long-term care facilities. CMS Rule. All provisions DEA Physician/Nurse Agent Definition. H.R. 891 The Medication Therapy Management Benefits Act of 2011. All provisions. S. 274 The Medication Management Empowerment Act of 2011. All provisions H.R. 1971/S. 1058, The Pharmacy Competition and Consumer Choice Act- All provisions H.R. 1946, The Preserving our Hometown Pharmacies Act-All provisions H.R. 971, The Commnit Pharmcy Fairness Act-All provisions H.R. 1936, The Medicare Access to Diabetes Supplies Act-All provisions Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   15000 0 0 2011-07-08T16:21:05.697000-04:00
1108850 UNIVERSITY OF IOWA e64a6183-f2c1-4dc3-82c4-70f8c3e531c5 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2011 second_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2011-07-08T16:38:20.290000-04:00
1109088 DUTKO WORLDWIDE, LLC 88802d2e-e0b6-4598-9327-2eeae5c3f570 Q2 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2011 second_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-11T11:26:13.657000-04:00
1109168 HOLLAND & KNIGHT LLP 317a6159-365e-446d-82e7-6d42ed02022e 2T HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2011 second_quarter PHA Hematology and Oncology drug research and approval issues. S. 296 Preserving Access to Life-Saving Medications Act. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 1 2011-07-11T12:02:58.890000-04:00
1109192 HOLLAND & KNIGHT LLP 6a9d74ff-c691-4d13-9e68-af110e2ca8cb 2T HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2011 second_quarter PHA Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 1 2011-07-11T12:08:08.093000-04:00
1109464 AMERICAN COLLEGE OF CLINICAL PHARMACY c604db59-9568-432b-91bb-b3e54d544075 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 second_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-07-11T14:57:37.943000-04:00
1110334 AMERICAN VETERINARY MEDICAL ASSOCIATION a760cad4-38fb-4b7f-8812-86513e0548fa Q2 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2011 second_quarter PHA H.R. 962/S. 1211 Preservation of Antibiotics for Medical Treatment Act H.R. 1406 Fairness to Pet Owners Act Agriculture, Dept of (USDA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2011-07-12T15:29:02.597000-04:00
1111007 VENABLE LLP 61d9f255-50c0-416e-a264-7dc5d6e805a9 Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2011 second_quarter PHA General issues affecting the pharmaceutical industry The Life Sciences Investment Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-13T11:09:32.397000-04:00
1112073 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 300de1dc-ecb0-468e-a302-8f89be1c780f Q2 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2011 second_quarter PHA Support legislation that would allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-14T10:40:04.627000-04:00
1113250 MCKENNA, LONG & ALDRIDGE 3d5ebf68-0236-4bf7-9a95-904ab5b55689 Q2 MCKENNA, LONG & ALDRIDGE 76913 REVANCE THERAPEUTICS, INC. 2011 second_quarter PHA Any issues impacting biopharmaceutical companies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-14T22:14:35.867000-04:00
1113432 PD FRAZER CONSULTING, INC. 45267b38-de9b-4d1c-a0b3-d3b42e3009ac Q2 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2011 second_quarter PHA Monitor the development of proposed bills about the importation of prescribed drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-15T09:38:59.827000-04:00
1113442 PD FRAZER CONSULTING, INC. be0fa0c4-b837-43c8-89a4-4f42161e8aec Q2 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2011 second_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-15T09:48:07.313000-04:00
1113541 THE OB-C GROUP, LLC d7ac7f70-1900-4dfe-b34d-f50f25a687f9 Q2 THE OB-C GROUP, LLC 29802 ELI LILLY 2011 second_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-15T10:42:01.487000-04:00
1113767 RASKY PARTNERS, INC. 91ac2923-2548-4017-b30e-790d18527738 Q2 RASKY PARTNERS, INC. 297410 ELI LILLY AND CO 2011 second_quarter PHA Monitor biologics related issues HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2011-07-15T11:41:02.987000-04:00
1114072 FAEGRE BAKER DANIELS CONSULTING 8625094f-8486-4584-b854-192170444ca6 Q2 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2011 second_quarter PHA ONLINE PHARMACIES Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-15T12:49:47.940000-04:00
1114518 GENENTECH, INC c0acace8-c62f-489c-b8d4-47049f65432c Q2 GENENTECH, INC 15920 GENENTECH INC 2011 second_quarter PHA Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicar prescription drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription. drug benefit. General issue and congressional oversight related to FDA approval and CMS coverage decisions regarding. Avastin and Lucentis. HOUSE OF REPRESENTATIVES,SENATE   1140295 0 0 2011-07-15T15:29:33.307000-04:00
1114565 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) a565f6e7-997e-4827-9753-c222d5dec955 Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2011 second_quarter PHA Importation of prescription drugs (S. 319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245); Cargo/Product Theft (S. 1002); Issues related to DEA drug diversion programs Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   272000 0 0 2011-07-15T15:39:54.980000-04:00
1114678 NOVO NORDISK INC. 4f90aa5a-f3d0-460a-88d1-e6b185ee2f97 Q2 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2011 second_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE   550000 0 0 2011-07-15T16:34:57.150000-04:00
1114796 NAHIGIAN STRATEGIES, LLC 112002fe-a502-41d8-9d81-1386b0832321 Q2 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2011 second_quarter PHA Generic Pharmaceutical Issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-15T17:09:45.290000-04:00
1114835 RED+BLUE STRATEGIES 993fe83e-a2d6-48ea-b949-2eaaf357a39f Q2 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2011 second_quarter PHA H.R. 2182, the Generating Antibiotic Incentives Now Act, in support of innovations in the development of new antibiotics Issues related to upstream and downstream supply chain safety Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-15T17:18:16.807000-04:00
1115037 THORN RUN PARTNERS 372041e0-1a58-4520-bbdd-4183ce001f77 Q2 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2011 second_quarter PHA Issues related to the implementation of the Affordable Care Act (ACA) and DEA enforcement of controlled substances in nursing homes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-16T14:05:25.363000-04:00
1115442 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC b604e3fa-bbbb-4f0d-a64a-ecb5c025efbf Q2 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2011 second_quarter PHA Preemption under the FDA Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-17T16:53:27.630000-04:00
1115913 SQUIRE PATTON BOGGS 99bd03d6-bd66-47ac-8bc8-1116ca275083 Q2 SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2011 second_quarter PHA S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S. 23/H.R. 1249 the America Invents Act; H.R. 1, Full Year Continuing Appropriations Act; H.R. 2112, Agriculture, Rural Development, Food & Drug Administration, and Related Agencies Appropriations Act of 2012. HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2011-07-18T07:51:59.517000-04:00
1116097 ALCALDE & FAY 68895267-0d78-421b-bb90-8b93171599fd Q2 ALCALDE & FAY 818 CITY OF KENMORE, WASHINGTON 2011 second_quarter PHA Expired drug reclamation programs Army, Dept of (Corps of Engineers),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T09:21:22.010000-04:00
1116136 EISAI INC. 6e98dad6-4517-4475-a6c8-cb5b184336b6 Q2 EISAI INC. 400321512 EISAI INC. 2011 second_quarter PHA Drug issues, generally. Prescription Drug User Fee Act reauthorization. FDA-DEA issues biosimilars implementation HOUSE OF REPRESENTATIVES,SENATE   670000 0 0 2011-07-18T09:31:38.217000-04:00
1116144 ACADEMY OF MANAGED CARE PHARMACY 954799f7-6324-49a9-b2f8-e93bbbe8f03b Q2 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2011 second_quarter PHA S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufacturer agrees to delay entry into the market in exchange for compensation from the manufacturer of the innovator product. HR 1483 - legislation that would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2011-07-18T09:32:41.903000-04:00
1116334 POLICY DIRECTIONS INC. e539144a-08d4-4d83-80bb-7261192c15f6 Q2 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2011 second_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-18T10:13:15.633000-04:00
1116491 WHITMER & WORRALL, LLC 195e8f5f-0d16-4e57-a9bf-89295f25134f Q2 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2011 second_quarter PHA Issues related to monitoring healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-18T10:31:27.120000-04:00
1116881 BROWN RUDNICK LLP 918dea0c-bfcd-4440-9aed-87dd6af1a03a Q2 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2011 second_quarter PHA Issues related to supply chain safety and DEA drug; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 S. 1002 - Safe Doses Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-18T11:22:23.837000-04:00
1116967 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS a959d414-3c7b-4a13-b8fc-9c36edd1f6b0 Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2011 second_quarter PHA Communication with Government Accountability Office concerning its study (required under section 7103, P.L. 111-148) on improving the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   250000 0 0 2011-07-18T11:34:05.757000-04:00
1117154 HEARTLAND SOLUTIONS GROUP, INC. a905ff39-5435-48e8-8d50-193d6effd776 Q2 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2011 second_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. Army, Dept of (Other),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-18T12:18:45.430000-04:00
1117489 THE RUSSELL GROUP, INC. b6116080-2973-41fa-a978-7cfc68b42947 Q2 THE RUSSELL GROUP, INC. 22688 GENERIC PHARMACEUTICAL ASSOCIATION 2011 second_quarter PHA Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 50000   0 0 2011-07-18T13:29:37.773000-04:00
1117959 EMPIRE CONSULTING GROUP f85956c1-ff3d-4a57-80ed-f5dbff28013a Q2 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2011 second_quarter PHA H.R. 1249 "America Invents Act" (Patent Reform); H.R. 452, Independent Payment Advisory Board ("IPAB") Repeal; Medicare Part D Rebates (during deficit reduction discussions); and Prescription Drug Diversion HOUSE OF REPRESENTATIVES 30000   0 0 2011-07-18T14:32:21.647000-04:00
1118204 SMITH GARSON FKA SMITH DAWSON & ANDREWS c0220ad9-2cc4-4e96-9011-0107be06d716 2T SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 STRUVE SWINE TECHNOLOGIES 2011 second_quarter PHA Government Advertisement of Biopharmaceuticals       0 1 2011-07-18T14:59:28.083000-04:00
1118211 SMITH GARSON FKA SMITH DAWSON & ANDREWS 22b08f3a-42d9-40fe-9af0-5422feb1ca90 2T SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 PROSETTA CORPORATION 2011 second_quarter PHA Government Advertisement of Biopharmaceuticals       0 1 2011-07-18T14:59:32.067000-04:00
1118309 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 7414be3a-106a-429f-a7fd-9ab751d08626 Q2 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2011 second_quarter PHA H.R. 1409: All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274: All provisions of the Medication Therapy Management Benefits Act of 2011; H.R. 905 /S. 733:All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; H.R. 979All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 605 / S. 312All provisions of the Patients Freedom to Choose Act S. 27 All provisions of the Preserve Access to Affordable Generics Act S. 31All provisions of the Prescription Drug and Health Improvement Act of 2011 S. 44All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011 H.R. 999 / S. 560All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011 H.R. 1839 All provisions of the Community Pharmacy Fairness Act of 2011; H.R. 1946 All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011; H.R. 1971 / S. 1058 All provisions of the Pharmacy Competition and Consumer Choice Act of 2011 Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio) Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs FDA issues related to the Prescription Drug User Fee Act (PD… Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   524738 0 0 2011-07-18T15:14:20.377000-04:00
1119634 SQUIRE PATTON BOGGS c85dccf9-e6b4-4650-9ad0-922333419c76 Q2 SQUIRE PATTON BOGGS 30906 KV PHARMACEUTICAL COMPANY 2011 second_quarter PHA Prescription drug coverage and pricing for progesterone injection. HOUSE OF REPRESENTATIVES,SENATE 310000   0 0 2011-07-19T08:01:11.407000-04:00
1119647 SQUIRE PATTON BOGGS c9360c63-62f9-4dbc-9585-9acef8600a1c Q2 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2011 second_quarter PHA Issues related to respiratory drug coverage and H.R. 3590. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-19T08:07:19.937000-04:00
1119863 UPS (UNITED PARCEL SERVICE) 6fb6a0e0-391f-4c48-83f7-016e985f1c57 Q2 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2011 second_quarter PHA - FDA Track and Trace - HHS/CDC PEPFAR Grant for Supply - Pedigree - Serialization Commerce, Dept of (DOC),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   1069998 0 0 2011-07-19T09:38:08.140000-04:00
1120133 CAPITOL HILL CONSULTING GROUP acdba1f8-d4e5-43c1-accd-bd805a709fe5 Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2011 second_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-19T10:16:10.187000-04:00
1120473 MCDERMOTT WILL & SCHULTE LLP 63e89ea4-62c0-403a-aff8-6d0f9e178911 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2011 second_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2011-07-19T10:50:42.557000-04:00
1121834 VAN SCOYOC ASSOCIATES 7e80aa95-297d-4755-b8fb-17074a394e9a Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2011 second_quarter PHA FDA salaries and expenses; and extramural research related issues: H.R.2112,Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T12:59:04.103000-04:00
1121850 VAN SCOYOC ASSOCIATES 46b3f3e7-ba4d-4d86-981d-8b41e8a3299a Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2011 second_quarter PHA No lobbying activity. Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-07-19T13:01:11.743000-04:00
1121871 VAN SCOYOC ASSOCIATES 4cf1fb09-3114-4918-a493-3a59f0074644 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2011 second_quarter PHA FDA and USDA funding initiatives; Critical Path Partnership. H.R.2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012 Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T13:01:18.790000-04:00
1122017 EXPRESS SCRIPTS, INC. 7b454d19-0fe2-440f-8b8f-e8246a13c441 Q2 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2011 second_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (essential health benefits, grandfathering, value-base insurance design, Rx quality, electronic prescribing, PBM disclosure requirements, medical loss ratio); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; Implementation of Zadroga Health Care Act; Legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058) Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office   450000 0 0 2011-07-19T13:22:18.117000-04:00
1122135 MCDERMOTT WILL & SCHULTE LLP cab922a1-4dad-4805-8259-15456a2823ab Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2011 second_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-07-19T13:34:15.523000-04:00
1122206 ELI LILLY AND COMPANY 9916fbe2-eee2-4bb7-9639-503cfafb46b1 Q2 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2011 second_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   1945000 0 0 2011-07-19T13:41:45.523000-04:00
1122402 MCDERMOTT WILL & SCHULTE LLP 2ffab682-02c4-40c2-bae1-421e6cb6fb0b Q2 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2011 second_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T14:04:20.117000-04:00
1122452 AKIN GUMP STRAUSS HAUER & FELD a9d12bfc-1453-4cf6-bb69-840611967de1 Q2 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2011 second_quarter PHA Promoting consumer benefits of authorized generic drugs Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-19T14:08:44.053000-04:00
1122552 BUCHANAN INGERSOLL & ROONEY PC 3ea5b65f-f3d8-4de3-91ab-dd6dbb74b9b1 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2011 second_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-19T14:16:23.747000-04:00
1122585 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION b7d97fe0-2bf6-4e10-afd8-d523a7285fbc Q2 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2011 second_quarter PHA Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2011-07-19T14:19:36.733000-04:00
1122753 APOTEX CORP. f954f602-f0db-4c71-82e1-e677617cbfc2 Q2 APOTEX CORP. 310973 APOTEX CORP. 2011 second_quarter PHA S. 27, the Preserve Access to Affordable Pharmaceuticals Act Amending Section 505(j) of the Food, Drug, and Comsetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Carco Pharmaceutical Laboratories Ltd and Sun Pharmaceuticals Industries, Ltd Prospective action on legislation establishing a generic drug user fee program Prospection action on legislation establishing a biosimilar user fee program S. 296, the Preserving Access to Life Saving Medications Act Establishment of a federal track and trace system for pharmaceuticals Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2011-07-19T14:32:49.823000-04:00
1122768 GOVBIZ ADVANTAGE, INC. 2444ad2e-52d1-4ba1-a12c-7b329424f9f5 Q2 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2011 second_quarter PHA Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T14:34:57.010000-04:00
1122832 BUCHANAN INGERSOLL & ROONEY PC 9e2f4cdf-7d05-4f13-bba1-0d55cfd68fa3 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 IPEC - AMERICAS, INC. 2011 second_quarter PHA FDA Globalization Acts and legislation related to supply chain security and drug contamination issues Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T14:41:28.433000-04:00
1122843 EVERTZ GROUP LLC 4536572c-7dc2-47ca-b7d3-4465c61615a1 Q2 EVERTZ GROUP LLC 400497446 MYLAN INC. 2011 second_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2011-07-19T14:41:33.150000-04:00
1122969 BUCHANAN INGERSOLL & ROONEY PC 4906f981-53ec-4e7b-9863-4e8ca04750fb Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO 2011 second_quarter PHA Patent reform, drug importation; Life Science Investment Act; drug exception from Pharma fee; medical device tax. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-19T14:49:28.383000-04:00
1123245 HANCE SCARBOROUGH a13c7807-4bb6-49a9-aba2-2dd359ee479d Q2 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2011 second_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-19T15:06:33.900000-04:00
1123845 NATIONAL ASSOCIATION OF CHAIN DRUG STORES d767c79c-9aec-4682-919e-67e732f36e32 Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2011 second_quarter PHA S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE   580000 0 0 2011-07-19T15:48:54.523000-04:00
1124017 HANCE SCARBOROUGH ddbb5860-9b7f-4c75-863a-0dd7aa50540f Q2 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2011 second_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-07-19T16:03:24.650000-04:00
1124083 AMYLIN PHARMACEUTICALS 9ad56e7c-4f41-47c2-b396-efbe5f2c3b36 Q2 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2011 second_quarter PHA Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2011-07-19T16:09:54.103000-04:00
1124167 UNIVERSITY OF CONNECTICUT aec658b1-0eae-48cf-bfc0-7c887b3000d9 Q2 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2011 second_quarter PHA FDA Salaries and expenses; and extramural research related issues: H.R.2112, Agriculture, Rural Developmetn, Food and Drug Administration and Related Ageneies Appropriations Act, FY2012. Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011. Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY-2011; Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2011-07-19T16:15:31.460000-04:00
1124295 AMERICAN PHARMACISTS ASSOCIATION 4329ab28-0f49-4cbc-b438-db5c005bc15b Q2 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2011 second_quarter PHA S.48 Pharmacist Loan Repayment Eligibility Act of 2011 Agency issues relating to risk evaluation and mitigation strategies (REMS); the Prescription Drug User Fee Act (PDUFA); prescription drug monitoring programs; prescription drug abuse; and safety of the drug supply chain. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   167951 0 0 2011-07-19T16:24:41.697000-04:00
1124314 BATES CAPITOL GROUP, INC. 4f2278cf-bfd5-4260-b7ab-02cdfcbc184f Q2 BATES CAPITOL GROUP, INC. 400656969 C2 GROUP (ON BEHALF OF BIOTECHNOLOGY INDUSTRY ORGANIZATION) 2011 second_quarter PHA Support strong and fully funded FDA review process. SENATE 20000   0 0 2011-07-19T16:27:01.273000-04:00
1124518 VAN HEUVELEN STRATEGIES, LLC a5efa27e-d9ad-4f9f-be5e-eceae2c8d74e Q2 VAN HEUVELEN STRATEGIES, LLC 321874 DAVITA 2011 second_quarter PHA Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. HOUSE OF REPRESENTATIVES,SENATE 210000   0 0 2011-07-19T16:37:21.523000-04:00
1125089 GEPHARDT GROUP GOVERNMENT AFFAIRS 357a9104-20ff-46f3-a31c-b230c0aff68a Q2 GEPHARDT GROUP GOVERNMENT AFFAIRS 315717 HEALIANCE PHARMACEUTICALS 2011 second_quarter PHA innovative diabetes treatment HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE,State, Dept of (DOS),Treasury, Dept of 20000   0 0 2011-07-19T17:12:50.803000-04:00
1125146 340B HEALTH a8aeb5d0-d98f-4597-a24b-84eeddb9dc65 Q2 340B HEALTH 316434 340B HEALTH 2011 second_quarter PHA Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals; Improving program integrity. Preserving 340B patient definition and Medicaid reimbursement to 340B covered entities. Reversing 340B orphan drug prohibition for certain covered entities. Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   262810 0 0 2011-07-19T17:17:15.520000-04:00
1125171 TARPLIN, DOWNS & YOUNG, LLC 50c1c388-eed0-4fc1-9063-65257bfe7220 Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2011 second_quarter PHA **see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296/H.R. 2245) Rx Pedigree Cargo/Product Theft (S. 1002) **no specific bills, federal pedigree, import safety Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-07-19T17:19:25.523000-04:00
1125323 ASSOCIATION FOR ACCESSIBLE MEDICINES 4897cbc8-4d12-4475-b1fd-80ef8aa0d7e6 Q2 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2011 second_quarter PHA FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug User Fees, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office   508375 0 0 2011-07-19T17:28:24.007000-04:00
1125349 FOLEY & LARDNER LLP 845a75ad-9d6a-413b-8eaa-e9e01c623a32 Q2 FOLEY & LARDNER LLP 15042 ROMARK LABORATORIES, LC 2011 second_quarter PHA Sale of new anti-viral drug Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-19T17:29:34.710000-04:00
1125432 GREATER NEW YORK HOSPITAL ASSOCIATION 8a23e2f8-4484-4705-8b18-1cc4ee9f287b Q2 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2011 second_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   470000 0 0 2011-07-19T17:34:05.897000-04:00
1125793 GREENBERG TRAURIG, LLP f2fa1c85-0f4f-4fb6-9c26-1c1f3eef44ee Q2 GREENBERG TRAURIG, LLP 16896 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) 2011 second_quarter PHA Health care legislative and regulatory issues affecting independent community pharmacies. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 20000   0 0 2011-07-19T18:09:43.397000-04:00
1125838 GREENBERG TRAURIG, LLP 0edf6295-7951-4e73-8269-62ea4637c207 Q2 GREENBERG TRAURIG, LLP 16896 RICHIE & GUERINGER, P.C. 2011 second_quarter PHA Congressional actions on health care reform. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-07-19T18:15:05.943000-04:00
1125939 BLUESTONE STRATEGIES, LLC f797d403-7730-4a14-ad86-1d9d82042ada Q2 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2011 second_quarter PHA Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; Speciality Drug Issues Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T18:25:49.740000-04:00
1126023 MARSHFIELD CLINIC HEALTH SYSTEM 2c6d964d-3357-4b54-9677-b2c937d1392b Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2011 second_quarter PHA Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2011-07-19T18:46:25.220000-04:00
1126374 SHIRE PHARMACEUTICALS LLC f281434a-1bfe-4213-8ec3-aa932f2838d8 Q2 SHIRE PHARMACEUTICALS LLC 323477 SHIRE PHARMACEUTICALS LLC 2011 second_quarter PHA S. 296, Preserving Access to Life Saving Medicines Act; Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas SENATE   90000 0 0 2011-07-19T20:02:59.487000-04:00
1126410 WINBORN SOLUTIONS LLC c591644f-2426-4db3-a39c-9ec04402655a Q2 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2011 second_quarter PHA Generic drug user fee legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2011-07-19T20:10:17.987000-04:00
1126459 DOW LOHNES GOVERNMENT STRATEGIES LLC c42fffa4-154f-4ae8-a06f-0b3eaaf9c0b7 Q2 DOW LOHNES GOVERNMENT STRATEGIES LLC 316013 AMERISOURCEBERGEN CORPORATION 2011 second_quarter PHA H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree history, wholesale transaction documentation, and electronic tracking; Federal policy related to wet AMD pharmaceutical products and pricing. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-07-19T20:25:41.627000-04:00
1126655 AVENUE SOLUTIONS 6d48df77-92e8-42c4-b311-63230781cac6 Q2 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2011 second_quarter PHA Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service and 5-day mail delivery; HR 979, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 27, Preserve Access to Affordable Generics Act; HR 1041, Fairness in Medicare Bidding; HR 1946, Preserving Our Hometown Independent Pharmacies Act; S 1058, Pharmacy Competition and Consumer Choice Act of 2011 HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2011-07-19T21:37:24.017000-04:00
1127477 WINNING STRATEGIES WASHINGTON a26bb64f-17b3-4c7b-bf64-963da08cf475 2T WINNING STRATEGIES WASHINGTON 50796 MEDA PHARMACEUTICALS 2011 second_quarter PHA FDA Risk Evaluation and Mitigation Strategies HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2011-07-20T09:09:46.460000-04:00
1127485 NOSSAMAN LLP afa54004-8230-459e-b250-36da3f7a613e Q2 NOSSAMAN LLP 29846 AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") 2011 second_quarter PHA H.R.905 and S.733, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-07-20T09:11:52.270000-04:00
1128024 OMNICARE, INC. a98868eb-29d9-4a0e-8a5b-d36d1a605044 Q2 OMNICARE, INC. 321112 OMNICARE INC 2011 second_quarter PHA Modify Drug Enforcement Administration policy on dispensing of controlled substances to residents of nursing homes. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   98000 0 0 2011-07-20T09:54:51.083000-04:00
1128797 FOOD MARKETPLACE INC. c801d332-6a61-4bc7-b8d9-e079804c666c Q2 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2011 second_quarter PHA Proposed Rule: CMS-1345-P; Medicare Shared Savings Program; Accountable Care Organization (76 FR 19528) Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Federal Deposit Insurance Corporation (FDIC),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),SENATE,Treasury, Dept of,White House Office   610000 0 0 2011-07-20T10:44:29.270000-04:00
1129027 WALGREEN COMPANY 9098fb5d-3d4d-418d-aef0-37ee3f3e15cd Q2 WALGREEN COMPANY 309071 WALGREEN COMPANY 2011 second_quarter PHA Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. H.R.1540/S. 981- the "National Defense Authorization Act of FY 2012"- provisions related to the TRICARE program. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   630000 0 0 2011-07-20T10:57:14.267000-04:00
1129148 CVS HEALTH (AND SUBSIDIARIES) 739decf2-a4f6-45a1-926c-66c11b9866df Q2 CVS HEALTH (AND SUBSIDIARIES) 302778 CVS CAREMARK INC 2011 second_quarter PHA Issues related to drug safety and the drug supply chain. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   2287321 0 0 2011-07-20T11:05:06.580000-04:00
1129610 JONES PUBLIC AFFAIRS, INC. c9b527cf-4aa7-4079-bc96-ac6ca651dae1 Q2 JONES PUBLIC AFFAIRS, INC. 400738211 THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES) 2011 second_quarter PHA Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-07-20T11:27:18.017000-04:00
1129756 THE UNITED STATES PHARMACOPEIAL CONVENTION a67d678f-3c83-45ec-80cd-55931984befa Q2 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2011 second_quarter PHA - Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. - H.R. 1483, "Drug Safety Enhancement Act of 2011", regarding Section 102 on drug supply quality and safety. - H.R. 2227, "Medical Gas Safety Act", regarding Section 3, Regulation of Medical Gases. - H. 2112, "Agriculture Appropriations Bill, FY 2012", regarding support for FDA funding. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE   60000 0 0 2011-07-20T11:34:24.487000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1821.789ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API